欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Shewanella pealeana Nucleoside diphosphate kinase (ndk) CSB-YP015889STP
CSB-EP015889STP
CSB-BP015889STP
CSB-MP015889STP
CSB-EP015889STP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella pealeana Triosephosphate isomerase (tpiA) CSB-YP024102STP
CSB-EP024102STP
CSB-BP024102STP
CSB-MP024102STP
CSB-EP024102STP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella pealeana Glycine dehydrogenase [decarboxylating] (gcvP), partial CSB-YP009493STP
CSB-EP009493STP
CSB-BP009493STP
CSB-MP009493STP
CSB-EP009493STP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella pealeana Urocanate hydratase (hutU), partial CSB-YP025677STP
CSB-EP025677STP
CSB-BP025677STP
CSB-MP025677STP
CSB-EP025677STP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella pealeana ATP synthase subunit alpha (atpA), partial CSB-YP002344STP
CSB-EP002344STP
CSB-BP002344STP
CSB-MP002344STP
CSB-EP002344STP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Azorhizobium caulinodans Lipoyl synthase (lipA) CSB-YP012927DPR
CSB-EP012927DPR
CSB-BP012927DPR
CSB-MP012927DPR
CSB-EP012927DPR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii 40S ribosomal protein SA (CHLREDRAFT_126059) CSB-YP020485DSJ
CSB-EP020485DSJ
CSB-BP020485DSJ
CSB-MP020485DSJ
CSB-EP020485DSJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii Coiled-coil domain-containing protein 39 (CCDC39), partial CSB-YP004697DSJ
CSB-EP004697DSJ
CSB-BP004697DSJ
CSB-MP004697DSJ
CSB-EP004697DSJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii Flap endonuclease 1 (FEN1) CSB-YP008585DSJ
CSB-EP008585DSJ
CSB-BP008585DSJ
CSB-MP008585DSJ
CSB-EP008585DSJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Diacylglycerol kinase eta (CG34384), partial CSB-YP006837DLU
CSB-EP006837DLU
CSB-BP006837DLU
CSB-MP006837DLU
CSB-EP006837DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Coiled-coil domain-containing protein 56 (ccdc56), partial CSB-YP004715DIL1
CSB-EP004715DIL1
CSB-BP004715DIL1
CSB-MP004715DIL1
CSB-EP004715DIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frankia sp. Transaldolase (tal) CSB-YP023112FDY
CSB-EP023112FDY
CSB-BP023112FDY
CSB-MP023112FDY
CSB-EP023112FDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frankia sp. ATP synthase subunit alpha (atpA), partial CSB-YP002344FDY
CSB-EP002344FDY
CSB-BP002344FDY
CSB-MP002344FDY
CSB-EP002344FDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frankia sp. Translation initiation factor IF-2 (infB), partial CSB-YP015164FDY
CSB-EP015164FDY
CSB-BP015164FDY
CSB-MP015164FDY
CSB-EP015164FDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frankia sp. Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) CSB-YP022917FDY
CSB-EP022917FDY
CSB-BP022917FDY
CSB-MP022917FDY
CSB-EP022917FDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Frankia sp. Methionyl-tRNA formyltransferase (fmt) CSB-YP015150FDY
CSB-EP015150FDY
CSB-BP015150FDY
CSB-MP015150FDY
CSB-EP015150FDY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dinoroseobacter shibae Glycine cleavage system H protein (gcvH) CSB-YP009335DIB
CSB-EP009335DIB
CSB-BP009335DIB
CSB-MP009335DIB
CSB-EP009335DIB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dinoroseobacter shibae ATP synthase subunit a (atpB), partial CSB-YP015070DIB1
CSB-EP015070DIB1
CSB-BP015070DIB1
CSB-MP015070DIB1
CSB-EP015070DIB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dinoroseobacter shibae Triosephosphate isomerase (tpiA) CSB-YP024102DIB
CSB-EP024102DIB
CSB-BP024102DIB
CSB-MP024102DIB
CSB-EP024102DIB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dinoroseobacter shibae Thymidylate kinase (tmk) CSB-YP007226DIB
CSB-EP007226DIB
CSB-BP007226DIB
CSB-MP007226DIB
CSB-EP007226DIB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×